Antitumor function of microRNA-122 against hepatocellular carcinoma (Q38188460)

30 August 2017

title

Antitumor function of microRNA-122 against hepatocellular carcinoma (English)

1 reference

30 August 2017

1 reference

Kazuhiko Nakao

1

1 reference

30 August 2017

Hisamitsu Miyaaki

series ordinal

2

1 reference

30 August 2017

Tatsuki Ichikawa

series ordinal

3

1 reference

30 August 2017

publication date

17 February 2014

1 reference

Journal of Gastroenterology

30 August 2017

published in

1 reference

30 August 2017

volume

49

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

589-593

1 reference

miR-122, a paradigm for the role of microRNAs in the liver

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Regulation and biological function of the liver-specific miR-122.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

MiR-122 in hepatic function and liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Role of miR-122 and lipid metabolism in HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

MicroRNAs in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Dual Role of miR-122 in Molecular Pathogenesis of Viral Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Sequencing and bioinformatics-based analyses of the microRNA transcriptome in hepatitis B-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Enzymes of triacylglycerol synthesis and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Zinc finger protein ZBTB20 is a key repressor of alpha-fetoprotein gene transcription in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Epigenetic modulation of miR-122 facilitates human embryonic stem cell self-renewal and hepatocellular carcinoma proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Positive regulation of hepatic miR-122 expression by HNF4α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-014-0932-4

MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.

21 January 2018

1 reference

12 December 2020

Molecular pathogenesis of hepatocellular carcinoma

1 reference

12 December 2020

Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis

1 reference

12 December 2020

Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance

1 reference

12 December 2020

10.1007/S00535-014-0932-4

Identifiers

DOI

1 reference

30 August 2017

1 reference